HEALTH PRODUCT FOUND ADULTERATED
The Ministry of Health would like to alert members of the public to one (01) type of health product which has been tested by the Pharmacy Section, Department of Scientific Services, Ministry of Health and found to be adulterated with undeclared, potent western medicine.
The affected health product is listed as below:
|No.||Name of product||Manufacturer||Adulterated with|
|1.||Titan Capsules||Laboratory EMANSI, Russia|
The adulterant found in this product can cause adverse effects that are potentially hazardous to the people using them.
Tadalafil is a drug used to treat male impotency and can only be prescribed by a qualified doctor or physician. Among its side effects include nausea, vomiting, flushing and dizziness. In severe cases, it can also result in abnormal increase in heart rate, sudden loss of hearing and seizures.
The Ministry of Health has not issued any approval for the importation for the sale of this product. Following this finding, the product is not allowed to be imported and sold in Brunei Darussalam.
Members of the public who have purchased or used this product are advised to stop using it immediately. They should also consult a medical practitioner if they feel unwell or experience any undesirable reactions as a result of using the product.
Members of the public involved in the retail of this product (including online retail such as through Facebook, etc.) are hereby reminded that it is an offence under the Poisons Act 1956 to sell any product containing any substance controlled under the said Act and the penalty for such an offence upon conviction, is a fine of $8,000 or six months' imprisonment. Furthermore, if a person commits an Act that amounts to such a degree of negligence so as to endanger or be likely to endanger human life, then such person shall be guilty of an offence which carries a penalty of a fine of $16,000 and 12 months' imprisonment.
The Ministry of Health would also like to call upon the public for their cooperation to report to the Compliance and Licensing Section if this product is still found on the market in this country.
For further information and communication, the public may contact the Compliance and Licensing Section at 2393298 extension 208; send an e-mail to firstname.lastname@example.org; go directly to 1st Floor, Compliance and Licensing Section, Department of Pharmaceutical Services' Building, Kg. Madaras, Mukim Gadong A; or call the Talian Darussalam 123.
- E N D -
Reference : KK/PR/3
Date : 6 July 2019 / 3 Zulkaedah 1440H